2 results
Approved WMORecruiting
To determine the safety, feasibility, and tolerability of adding PIPAC with oxaliplatin (92 mg/m2) to systemic chemotherapy in patients with isolated PM from CRC.
Approved WMOCompleted
To study the potential of alkaline phosphatase to protect against ischemia-reperfusion injury in living donor kidney transplantation.